GNPX - Taking A Gander At Genprex March, 14 2021 02:18 PM Genprex Inc. Today, we are posting our first look at a small biotech concern called Genprex. Genprex has two early-stage drug candidates that are targeting NSCLC and diabetes. A full analysis follows in the paragraphs below. For further details see: Taking A Gander At Genprex